Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2005-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc2ae2ad17e14b8b4a449f51f96f867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19dbfbe70619892e6823d72a3c5c0d09 |
publicationDate |
2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-101119748-A |
titleOfInvention |
Pharmaceutical composition for treatment of diabetes |
abstract |
It is intended to provide a method of treating diabetes which exhibits an excellent effect, enables the regulation of side effects and has a high safety. To use a drug containing an FBPase inhibitor at a definite dosing point. |
priorityDate |
2004-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |